CDMRP Ovarian Cancer Research Program Clinical Translational Research Award

The summary for the CDMRP Ovarian Cancer Research Program Clinical Translational Research Award grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Dept of the Army USAMRAA, which is the U.S. government agency offering this grant.

CDMRP Ovarian Cancer Research Program Clinical Translational Research Award: The Clinical Translational Research Award is intended to support correlative studies that are associated with a clinical trial. The translational research should address high-impact or unmet needs in ovarian cancer. Applications focused on the following OCRP priority are encouraged to apply: Utilize precision medicine and computational approaches that identify individual tumor characteristics and predictive biomarkers across diverse groups to optimize patient care and outcomes. Although not intended to fund the operational aspects of clinical trials, this award supports research projects related to or associated with planned, ongoing, or completed clinical trials supported by other funding sources. Projects that develop clinical endpoints for clinical trials are also encouraged. The application must demonstrate availability and accessibility of the appropriate human subject population, specimens, or human-based resources. The application should also provide a detailed statistical analysis plan that includes a power analysis reflecting sample size projections that will allow a meaningful outcome. Preclinical studies in animals are not allowed.